A study led by Harvard Medical School, explored the reason that causes the rise of aortic aneurysms, thus offering vital ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...

Museveni made the remarks on Saturday while presiding over a thanksgiving ceremony organized by Prime Minister Robinah Nabbanja at Mpasana Seed Secondary School playground in Bugangaizi East County, ...

India ramps up Russian oil imports to 2-2.2 million bpd in June, outpacing Middle East supplies amid Israel-Iran conflict and ...

Speaking at a two-day training retreat at the Source of the Nile Hotel, Dr. Egessa Simplicious, Public Relations Officer at ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...